China Association for the promotion of drugs published an article in nature to show the major achievements of China's pharmaceutical innovation

Source: China pharmaceutical innovation promotion association may 5, 2017 Springer Nature, a subsidiary of nature, published a series of articles on the theme of "from imitation to innovation" organized by China Pharmaceutical Innovation Promotion Association (hereinafter referred to as "China pharmaceutical promotion association"), which systematically demonstrated the remarkable achievements made in the transformation of Chinese medicine from imitation to innovation in the past decade This column is composed of Ding liming, President of CFDA in 2016-2017, chairman and CEO of Beida Pharmaceutical Co., Ltd., song Ruilin, executive chairman of CFDA, Jiang Jiandong, President designate of CFDA, Institute of medicine of Chinese Academy of Medical Sciences, Jiang Hualiang, President of CFDA in 2015-2016, director of Shanghai Institute of medicine of Chinese Academy of Sciences and clinical special committee of CFDA Shi Yuankai, vice chairman and vice president of Cancer Hospital of Chinese Academy of Medical Sciences, respectively, from five aspects of China's pharmaceutical innovation policy driven, pharmaceutical basic research, construction of innovative drug platform, clinical research, systematically demonstrated that in recent years, under the support and guidance of the national innovation driven strategy, especially the major new drug innovation science and technology projects, China's innovative drugs The system layout of the complete industrial chain of R & D and technological innovation, the significant increase of R & D investment and invention patents in pharmaceutical innovation, the breakthrough of some key bottleneck technologies in R & D of innovative drugs, the significant progress in the construction of pharmaceutical basic research and professional technology platform, and the approval and listing of several landmark innovative drugs with international level and filling clinical gaps independently developed to promote The innovation transformation of the pharmaceutical industry and the construction of an innovative country provide new impetus and a new breakthrough Nature, founded in 1869, is one of the most authoritative scientific magazines in the world, with the mission of reporting major discoveries and breakthroughs in the scientific world Among a large number of comprehensive scientific journals, nature has been cited for the first time in the world, with an impact factor of 38.138 This time, Nature magazine published a series of review articles on the achievements of China's pharmaceutical innovation and development for the first time, which focused on the current situation and achievements of China's pharmaceutical innovation and development, fully showing the world's high concern and expectation for the innovation of China's pharmaceutical industry, and firmly believed that the continuous innovation of China's pharmaceutical industry will play a more important role in the field of global pharmaceutical innovation Chinese pharmaceutical innovation is an important part of global pharmaceutical innovation Although there are still many challenges in the development of Chinese pharmaceutical innovation, the pace of innovation has never stopped, especially in biomedicine and natural medicine, Chinese pharmaceutical innovation has shown a strong strength Adhering to the tenet of "innovation, industrialization and internationalization", China pharmaceutical promotion association has made some effective attempts in promoting pharmaceutical innovation and development We are convinced that the Chinese pharmaceutical innovation community needs to learn from the counterparts of advanced countries in the world, and the world also needs to understand the progress of Chinese pharmaceutical innovation China Council for the promotion of medicine has reached an agreement with Nature magazine The two sides will work closely together to publish relevant articles on the progress of China's pharmaceutical innovation every year, transmit China's information to the world, let the world know more about China, and further promote the development and cooperation of global pharmaceutical innovation Original reading: Nature